Kraig Biocraft Laboratories, Inc.
Calidad de datos: 83%
KBLB
OTC
Manufacturing
Chemicals
$0.14
▲
$0.01
(6.15%)
Cap. Mercado: 151.77 M
Precio
$0.14
Cap. Mercado
151.77 M
Rango del Día
$0.13 — $0.14
Rango de 52 Semanas
$0.07 — $0.15
Volumen
616,710
Apertura $0.13
Promedio 50D / 200D
$0.11
26.61% above
Promedio 50D / 200D
$0.09
51.65% above
Quick Summary
Puntos Clave
Negative free cash flow of -1.79 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio0.16
Interest Coverage-5.91
Valoración
PE (TTM)
-41.89
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -41.9 | -2.0 |
| P/B | — | 5.1 |
| ROE % | — | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -3.62 M |
| ROE | N/A | ROA | -183.56% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -1.79 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.16 |
| Interest Coverage | -5.91 | Asset Turnover | N/A |
| Working Capital | -8.54 M | Tangible Book Value | -7.96 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -41.89 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -1.18% | ||
| Market Cap | 151.77 M | Enterprise Value | 150.21 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.00 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 49.52% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -3.62 M | -3.40 M | -3.03 M | -3.84 M | -8.05 M |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -3.37 M | -3.07 M | -2.61 M | -2.12 M | -2.76 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 165,758.0 | 164,374.0 | 237,871.0 | 176,431.0 | 197,745.0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 570,709.0 | 529,603.0 | 153,955.0 | 153,955.0 | 238,110.0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.57 M | 1.51 M | 3.23 M | 4.57 M | 3.02 M |
| Total Liabilities | 10.56 M | 9.65 M | 8.94 M | 8.09 M | 8.32 M |
| Shareholders' Equity | -8.00 M | -8.15 M | -5.71 M | -3.52 M | -5.30 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 1.79 M | 673,264.0 | 2.55 M | — | — |
| Current Assets | 1.87 M | 740,285.0 | 2.57 M | 3.98 M | 2.37 M |
| Current Liabilities | 10.45 M | 9.61 M | 8.89 M | 8.07 M | 8.16 M |
{"event":"ticker_viewed","properties":{"ticker":"KBLB","listing_kind":"stock","pathname":"/stocks/kblb","exchange":"OTC","country":"US"}}